Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schennach

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Pharmacopsychiatry|October 8, 2010
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trialsR Schennach-Wolff, H-J Möller, M Jäger, et al.
Acta Psychiatrica Scandinavica|October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression ScaleR Schennach-Wolff, M Obermeier, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 4, 2010
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disordersR Schennach-Wolff, F Seemüller, M Obermeier, et al.
Acta Psychiatrica Scandinavica|November 3, 2009
Outcome of suicidal patients with schizophrenia: results from a naturalistic studyR Schennach-Wolff, M Jäger, F Seemüller, et al.
Schizophrenia Research|February 26, 2010
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patientsM Jäger, M Riedel, M Obermeier, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Pharmacopsychiatry|October 8, 2010
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trialsR Schennach-Wolff, H-J Möller, M Jäger, et al.
Acta Psychiatrica Scandinavica|October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression ScaleR Schennach-Wolff, M Obermeier, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 4, 2010
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disordersR Schennach-Wolff, F Seemüller, M Obermeier, et al.
Acta Psychiatrica Scandinavica|November 3, 2009
Outcome of suicidal patients with schizophrenia: results from a naturalistic studyR Schennach-Wolff, M Jäger, F Seemüller, et al.
Schizophrenia Research|February 26, 2010
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patientsM Jäger, M Riedel, M Obermeier, et al.
Pageof 3